Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Short term Debt (2019 - 2025)

Historic Short term Debt for Bioadaptives (BDPT) over the last 7 years, with Q3 2025 value amounting to $967406.0.

  • Bioadaptives' Short term Debt fell 593.98% to $967406.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $967406.0, marking a year-over-year decrease of 593.98%. This contributed to the annual value of $1.1 million for FY2024, which is 770.83% up from last year.
  • Per Bioadaptives' latest filing, its Short term Debt stood at $967406.0 for Q3 2025, which was down 593.98% from $860636.0 recorded in Q2 2025.
  • In the past 5 years, Bioadaptives' Short term Debt ranged from a high of $1.1 million in Q2 2024 and a low of $557042.0 during Q4 2021
  • For the 5-year period, Bioadaptives' Short term Debt averaged around $860753.3, with its median value being $874737.0 (2023).
  • Within the past 5 years, the most significant YoY rise in Bioadaptives' Short term Debt was 2590504.57% (2021), while the steepest drop was 3265.27% (2021).
  • Bioadaptives' Short term Debt (Quarter) stood at $557042.0 in 2021, then grew by 23.3% to $686856.0 in 2022, then soared by 42.37% to $977872.0 in 2023, then increased by 7.71% to $1.1 million in 2024, then decreased by 8.15% to $967406.0 in 2025.
  • Its Short term Debt stands at $967406.0 for Q3 2025, versus $860636.0 for Q2 2025 and $991590.0 for Q1 2025.